Value & Innovation Forum

The Value & Innovation Forum is a collaboration of the National Forum for Heart Disease & Stroke Prevention and Patient Advocate Foundation, both 501(c)(3) nonprofit organizations. Briefing topics are selected by the Value & Innovation Forum Steering Committee which includes representatives of the Alliance of Community Health Plans, Association of Black Cardiologists, Caregiver Action Network, and National Osteoporosis Foundation, in addition to the National Forum and Patient Advocate Foundation. Briefings are made possible by funding from Amgen in accordance with the National Forum’s Policy on Corporate and Foundation Support and Relationships. This policy ensures transparency and integrity in the National Forum’s dealings with sponsors.

The Value & Innovation Forum Presents What Are Z Codes and How Do They Impact Health Equity?

 

Our webinar briefing will educate attendees on how Z codes can help improve patient care and increase health equity. Z codes are a recent addition to healthcare diagnostic codes. They enable clinicians to document a patient’s social needs that impact their health.

Z codes have the potential to improve care and help patients address social determinants of health. But the codes are little used, and few people in healthcare, public health, or patient communities are familiar with them.

This briefing will cover the basics of Z codes and how they can bring social determinants of care out of the shadows into mainstream healthcare.

Moderator:

Alan Balch, PhD, Chief Executive Officer, Patient Advocate Foundation & National Patient Advocate Foundation

Dr. Balch has nearly fifteen years of executive leadership in the non-profit sector with an emphasis on consensus-building and collaboration. He has led numerous federal advocacy efforts on a range of issues both at the legislative and regulatory level over the years. He became the CEO of both PAF and NPAF in 2013. From 2006 – 2013, he served as the Vice President of the Preventive Health Partnership — a national health promotion collaboration between the American Cancer Society, American Diabetes Association, and American Heart Association. Prior to his work with the Preventive Health Partnership, Dr. Balch was the Executive Director of Friends of Cancer Research. Dr. Balch has served on the Executive Board of the Patient Advocate Foundation and National Patient Advocate Foundation since 2007. Dr. Balch also serves on numerous advisory boards and committees. 

Speakers:

Julia Resnick, Senior Program Manager for Strategic Initiatives, American Hospital Association

Julia Resnick is senior program manager for strategic initiatives at the American Hospital Association. In this role, she supports AHA’s efforts to guide hospitals as they promote value by implementing strategies that improve quality, enhance the patient experience and decrease cost. She also leads the organization’s work on the social determinants of health. Formerly, Julia led AHA’s Association for Community Health Improvement, a professional membership group for community health leaders. Prior to joining AHA, Julia worked in clinical research at NorthShore University HealthSystem. She received a Master of Public Health degree from Hebrew University and a BA in sociology from Bates College. 

Katlyn Sollenberger, Site Specialist, The Rinehart Clinic, Wheeler, OR

Katy Sollenberger is the EPIC Site Specialist at the Rinehart Clinic. In this role, she works closely with the Quality Director and Outreach and Enrollment Navigator to develop workflows around social determinates of health screenings and data tracking.  During this process, they implemented the use of Z-codes to help compile data on social determinates of health at the population level. By working with the medical team, they were able to overcome obstacles around conducting and documenting social determinates of health screenings and the implementation of Z-codes. 

Before her role at the Rinehart Clinic, Katy attended Portland State University where she received her bachelor’s degree in business administration. Using her education in business research and analytics, she helped quantify and explain the data from reports to help develop a better understanding of the metrics and how they can play a role in health care. 

Resources:

Proposed New Codes for SDOH Z Codes

2021 ICD-10-CM from CMS

Z Codes Infographic from CMS

Kaiser Permanente Infographic on Z Codes

American Hospital Association ICD-10-CM Coding for Social Determinants of Health

Briefings Archive

Telehealth: Patient Access & Equity - June 2, 2021

 

 

Webinar RecordingWebinar Summary

Speaker Bios

Shonta Chambers, MSW
Executive Vice President, Health Equity & Community Engagement
Principal Investigator, SelfMade Health Network
Patient Advocate Foundation

Barbara Hutchinson, MD PhD, FACC
President, Chesapeake Cardiac Care
Past President, Association of Black Cardiologists

Connie Hwang, MD, MPH
Chief Medical Officer, Director of Clinical Innovation
Alliance of Community Health Plans

Resources

Innovations and Alternatives to Traditional Utilization Management - December 14, 2020

Traditional utilization management has become burdensome for physicians and patients.  This 1-hour briefing brings forward innovative real-world examples to navigate utilization management.

Speakers
Kate Berry, Senior Vice President of Clinical Innovation, America’s Health Plans
Jay Scott, Director, Managed Care, Minnesota Oncology
Robin T. Zon, MD, FACP, FASCO Chair, ASCO Pathways Task Force
President, Finance & Quality Chair, Michiana Hematology-Oncology, PC

Moderator
Alan Balch, PhD, CEO, Patient Advocate Foundation, National Patient Advocate Foundation

Webinar Recording
Webinar Summary
Speaker Bios

Resources 

Sustaining Access & Choices for Patients: Exploring the Risks & Benefits of Traditional Medicare & Medicare Advantage - October 6, 2020

Increased focus on public options like “Medicare for All” along with historic increases in Medicare Advantage enrollment make this the right time for patient groups to learn more about different approaches and related policy issues!

Webinar Recording
     Welcome & Introduction (0:01)
     Tricia Neuman (4:25)
     Judith Stein (17:52)
     Michael Bagel (30:00)
     Discussion (40:00) 
Webinar Summary
Slides
Speaker Bios 

Resources 

Websites

Uptake and Pricing of Biosimilars & the "Rebate Wall": A Value & Innovation Forum Multi-Perspective Briefing - June 2, 2020

Biosimilars continue to be a controversial subject long after Congress created a pathway for their approval. The Value & Innovation Forum prides itself on creating forums that present all sides of an issue as well as new and interesting angles beyond the hotly debated. This session provides an interesting discussion about the “rebate wall” controversy in biosimilars, a patient perspective, and where the FDA is headed next.

Speakers

  • John M. Clymer, Executive Director, National Forum for Heart Disease & Stroke Prevention
  • Nicole Braccio, PharmD, Policy Director, National Patient Advocate Foundation
  • Christine Simmon, JD, Senior Vice President, Policy & Strategic Alliances, Executive Director, Biosimilars Council, Association for Accessible Medicines
  • Sarah Yim, MD, Director, Office of Therapeutic Biologics and Biosimilars, Office of New Drugs, Center for Drug Evaluation & Research, U.S. Food and Drug Administration
  • Chad Pettit, Executive Director, Global Value Access and Policy, Amgen
  • Madelaine Feldman, MD, Practicing Rheumatologist, Founding Member & Past President, Rheumatology Alliance of Louisiana

AGENDA

WELCOME

John M. ClymerJohn M. Clymer, Executive Director, National Forum for Heart Disease & Stroke Prevention
Bio


MODERATOR

Nicole Braccio, PharmD, Policy Director, National Patient Advocate Foundation
Bio

PANELISTS

Christine Simmon, Senior Vice President, Policy & Strategic Alliances, Executive Director, Biosimilars Council, Association for Accessible Medicines
Bio

Sarah Yim, MD, Director, Office of Therapeutic Biologics and Biosimilars, Office of New Drugs, Center for Drug Evaluation & Research, U.S. Food and Drug Administration
Bio 

Chad Pettit, Executive Director, Global Value Access and Policy, Amgen
Bio

Madelaine Feldman, MD, Practicing Rheumatologist, President, Coalition of State Rheumatology Organizations
Bio

Webinar Recording
Webinar Summary
Slides

Articles

White Paper

Websites

  • FDA Biosimilars for access to educational materials and information about biosimilar and interchangeable products.
  • Drugs@FDA for information on all FDA approved drug products, including labeling and review information.
  • FDA Advisory Committees for drug advisory committee meetings and materials related to biosimilars
  • FDA Purple Book a database of Licensed Biological Products for information on biological products, including if products are biosimilar to a reference product.
  • Amgen Biosimilars